FAP and lung carcinoma: For example, the clearance of FAP+ CAFs by chimeric antigen engineered T cells reduced the desmoplastic stromal structure and tumour vascular density, resulting in significant anti‐tumour effects in human lung cancer xenografts and syngeneic murine pancreatic cancers.66